MT-2 (Melanotan II) is a high-purity synthetic peptide supplied in a lyophilized powder format, intended strictly for laboratory research and development use. Produced to achieve purity levels exceeding 99% and verified through advanced HPLC and LC-MS testing methods, this compound is packaged in a sterile, sealed vial to help maintain stability, consistency, and overall product integrity during proper storage and handling.
Recent research & studies
- Photoactivated iridium(III) complexes drive pyroptosis-necroptosis synergy for multi-network photoimmunotherapy of renal cell carcinoma.
Recurrence and metastasis are the leading causes of mortality in renal cell carcinoma (RCC), and its intrinsic drug resistance further limits effective therapeutic options. Synergistic activation of multiple regulated cell death pathways has recently emerged as a novel approach to…
- Combined effects of melatonin and valproic acid in cerebral ischemia via modulation of oxidative stress and melatonin receptors.
Background: Ischemic stroke is a major cause of mortality and disability worldwide, with limited effective neuroprotective treatments. Epigenetic modulation and oxidative stress regulation have emerged as promising therapeutic targets. This study aimed to evaluate the neuroprotective effects of melatonin and…
- Functional delivery of commercially-available microRNA mimics to the organs of developing mice.
MicroRNA are pivotal regulators of organ and tissue homeostasis and development, and pathogenic mediators of disease. While antagonism of specific microRNA species in vivo is easily accomplished in experimental animal models using locked nucleic acid (LNA)-stabilized antimiRs, microRNA mimicry -that…
- Exploring the Use of Genetic and Behavioural Data in Tailoring Dietary and Lifestyle Support
Personalised nutrition approaches typically rely on static information such as health status, lifestyle and genetic data. However, adherence often remains low because daily behaviours are influenced by psychological states, motivation and real-time barriers. There is growing interest in whether integrating…
- A Study to Evaluate Sapablursen (Formerly ISIS 702843, IONIS-TMPRSS6-LRx) in Patients With Polycythemia Vera
The main purpose of this study is to evaluate the efficacy of sapablursen in reducing the frequency of phlebotomy and in improving quality of life assessments in participants with polycythemia vera.
- A Study to Test the Safety, Tolerability, and Efficacy of an Antibody, REGN7999, Injected Under the Skin for the Treatment of Iron Overload in Adult Participants With Non-Transfusion Dependent β-thalassemia, Using MRI Scans to Measure Iron Levels in the Body
This study is researching an experimental drug called REGN7999 (called "study drug"). The study is focused on patients with non-transfusion dependent beta-thalassemia. The aim of the study is to see how safe and effective the study drug is. The study…
These are third-party research studies presented for informational purposes. They are not endorsements and do not constitute medical advice or claims about any product.
